Stericycle (Nasdaq: SRCL) reported earnings on Oct. 24. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended Sep. 30 (Q3), Stericycle met expectations on revenues and beat slightly on earnings per share.
Compared to the prior-year quarter, revenue increased and GAAP earnings per share expanded.
Margins dropped across the board.
Revenue details
Stericycle booked revenue of $480.5 million. The 12 analysts polled by S&P Capital IQ predicted a top line of $477.4 million on the same basis. GAAP reported sales were 14% higher than the prior-year quarter's $420.9 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS details
EPS came in at $0.84. The 14 earnings estimates compiled by S&P Capital IQ predicted $0.82 per share. GAAP EPS of $0.75 for Q3 were 10% higher than the prior-year quarter's $0.68 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
Margin details
For the quarter, gross margin was 44.9%, 270 basis points worse than the prior-year quarter. Operating margin was 26.1%, 30 basis points worse than the prior-year quarter. Net margin was 13.6%, 50 basis points worse than the prior-year quarter.
Looking ahead
Next quarter's average estimate for revenue is $487.9 million. On the bottom line, the average EPS estimate is $0.86.
Next year's average estimate for revenue is $1.89 billion. The average EPS estimate is $3.27.
Investor sentiment
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 286 members out of 311 rating the stock outperform, and 25 members rating it underperform. Among 82 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 75 give Stericycle a green thumbs-up, and seven give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Stericycle is outperform, with an average price target of $97.50.
- Add Stericycle to My Watchlist.





